- call +1-201-465-4211
- email sales@mrinsights.biz
A measurable DNA and/or RNA characteristic that is an indicator of normal biologic processes, pathogenic processes, and/or response to therapeutic or other interventions.
Scope of the Report:
Major factors contributing to the growth of the global genomic biomarker market include increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, neurological disorders and others. Other driving factors include increasing research and investment in the field of genomic biomarkers and use of genomic biomarker services for the enhancement of drug development pipelines.
The global Genomic Biomarker market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Genomic Biomarker.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Genomic Biomarker market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Genomic Biomarker market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oncology
Cardiology
Neurology
Nephrology
Market Segment by Applications, can be divided into
Hospitals
Diagnostic and research laboratories
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Genomic Biomarker Market Overview
1.1 Product Overview and Scope of Genomic Biomarker
1.2 Classification of Genomic Biomarker by Types
1.2.1 Global Genomic Biomarker Revenue Comparison by Types (2017-2023)
1.2.2 Global Genomic Biomarker Revenue Market Share by Types in 2017
1.2.3 Oncology
1.2.4 Cardiology
1.2.5 Neurology
1.2.6 Nephrology
1.3 Global Genomic Biomarker Market by Application
1.3.1 Global Genomic Biomarker Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Diagnostic and research laboratories
1.4 Global Genomic Biomarker Market by Regions
1.4.1 Global Genomic Biomarker Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Genomic Biomarker Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Genomic Biomarker Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomic Biomarker Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Genomic Biomarker Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomic Biomarker Status and Prospect (2013-2023)
1.5 Global Market Size of Genomic Biomarker (2013-2023)
2 Manufacturers Profiles
2.1 Bio-Rad
2.1.1 Business Overview
2.1.2 Genomic Biomarker Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bio-Rad Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.2 Beckman Coulter
2.2.1 Business Overview
2.2.2 Genomic Biomarker Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Beckman Coulter Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.3 Myriad Genetics
2.3.1 Business Overview
2.3.2 Genomic Biomarker Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Myriad Genetics Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.4 Thermo Fisher Scientific
2.4.1 Business Overview
2.4.2 Genomic Biomarker Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fisher Scientific Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Genomic Biomarker Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.6 QIAGEN
2.6.1 Business Overview
2.6.2 Genomic Biomarker Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 QIAGEN Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.7 Epigenomics
2.7.1 Business Overview
2.7.2 Genomic Biomarker Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Epigenomics Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.8 Almac
2.8.1 Business Overview
2.8.2 Genomic Biomarker Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Almac Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Genomic Biomarker Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.10 Human Longevity
2.10.1 Business Overview
2.10.2 Genomic Biomarker Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Human Longevity Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.11 ValiRx
2.11.1 Business Overview
2.11.2 Genomic Biomarker Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 ValiRx Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.12 Personalis
2.12.1 Business Overview
2.12.2 Genomic Biomarker Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Personalis Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.13 Eagle Genomics
2.13.1 Business Overview
2.13.2 Genomic Biomarker Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Eagle Genomics Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.14 Empire Genomics
2.14.1 Business Overview
2.14.2 Genomic Biomarker Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Empire Genomics Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.15 Agilent
2.15.1 Business Overview
2.15.2 Genomic Biomarker Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Agilent Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
2.16 Illumina
2.16.1 Business Overview
2.16.2 Genomic Biomarker Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Illumina Genomic Biomarker Revenue, Gross Margin and Market Share (2016-2017)
3 Global Genomic Biomarker Market Competition, by Players
3.1 Global Genomic Biomarker Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Genomic Biomarker Players Market Share
3.2.2 Top 10 Genomic Biomarker Players Market Share
3.3 Market Competition Trend
4 Global Genomic Biomarker Market Size by Regions
4.1 Global Genomic Biomarker Revenue and Market Share by Regions
4.2 North America Genomic Biomarker Revenue and Growth Rate (2013-2018)
4.3 Europe Genomic Biomarker Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Genomic Biomarker Revenue and Growth Rate (2013-2018)
4.5 South America Genomic Biomarker Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Genomic Biomarker Revenue and Growth Rate (2013-2018)
5 North America Genomic Biomarker Revenue by Countries
5.1 North America Genomic Biomarker Revenue by Countries (2013-2018)
5.2 USA Genomic Biomarker Revenue and Growth Rate (2013-2018)
5.3 Canada Genomic Biomarker Revenue and Growth Rate (2013-2018)
5.4 Mexico Genomic Biomarker Revenue and Growth Rate (2013-2018)
6 Europe Genomic Biomarker Revenue by Countries
6.1 Europe Genomic Biomarker Revenue by Countries (2013-2018)
6.2 Germany Genomic Biomarker Revenue and Growth Rate (2013-2018)
6.3 UK Genomic Biomarker Revenue and Growth Rate (2013-2018)
6.4 France Genomic Biomarker Revenue and Growth Rate (2013-2018)
6.5 Russia Genomic Biomarker Revenue and Growth Rate (2013-2018)
6.6 Italy Genomic Biomarker Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Genomic Biomarker Revenue by Countries
7.1 Asia-Pacific Genomic Biomarker Revenue by Countries (2013-2018)
7.2 China Genomic Biomarker Revenue and Growth Rate (2013-2018)
7.3 Japan Genomic Biomarker Revenue and Growth Rate (2013-2018)
7.4 Korea Genomic Biomarker Revenue and Growth Rate (2013-2018)
7.5 India Genomic Biomarker Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Genomic Biomarker Revenue and Growth Rate (2013-2018)
8 South America Genomic Biomarker Revenue by Countries
8.1 South America Genomic Biomarker Revenue by Countries (2013-2018)
8.2 Brazil Genomic Biomarker Revenue and Growth Rate (2013-2018)
8.3 Argentina Genomic Biomarker Revenue and Growth Rate (2013-2018)
8.4 Colombia Genomic Biomarker Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Genomic Biomarker by Countries
9.1 Middle East and Africa Genomic Biomarker Revenue by Countries (2013-2018)
9.2 Saudi Arabia Genomic Biomarker Revenue and Growth Rate (2013-2018)
9.3 UAE Genomic Biomarker Revenue and Growth Rate (2013-2018)
9.4 Egypt Genomic Biomarker Revenue and Growth Rate (2013-2018)
9.5 Nigeria Genomic Biomarker Revenue and Growth Rate (2013-2018)
9.6 South Africa Genomic Biomarker Revenue and Growth Rate (2013-2018)
10 Global Genomic Biomarker Market Segment by Type
10.1 Global Genomic Biomarker Revenue and Market Share by Type (2013-2018)
10.2 Global Genomic Biomarker Market Forecast by Type (2018-2023)
10.3 Oncology Revenue Growth Rate (2013-2023)
10.4 Cardiology Revenue Growth Rate (2013-2023)
10.5 Neurology Revenue Growth Rate (2013-2023)
10.6 Nephrology Revenue Growth Rate (2013-2023)
11 Global Genomic Biomarker Market Segment by Application
11.1 Global Genomic Biomarker Revenue Market Share by Application (2013-2018)
11.2 Genomic Biomarker Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Diagnostic and research laboratories Revenue Growth (2013-2018)
12 Global Genomic Biomarker Market Size Forecast (2018-2023)
12.1 Global Genomic Biomarker Market Size Forecast (2018-2023)
12.2 Global Genomic Biomarker Market Forecast by Regions (2018-2023)
12.3 North America Genomic Biomarker Revenue Market Forecast (2018-2023)
12.4 Europe Genomic Biomarker Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Genomic Biomarker Revenue Market Forecast (2018-2023)
12.6 South America Genomic Biomarker Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Genomic Biomarker Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Genomic Biomarker Picture
Table Product Specifications of Genomic Biomarker
Table Global Genomic Biomarker and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
